Innovative
Therapeutics for
Better Health

Because Life
Shouldn't Have to
Wait for Migraines

Our Lead Product Candidate

STS101

Dihydroergotamine (DHE) Nasal Powder

Learn More

Clinical Trials

SUMMIT™ Trial

Currently Recruiting

Learn More

Clinical Trials

ASCEND™ Trial

Ongoing

Learn More

Press Releases

Oct 12, 2021

Satsuma Pharmaceuticals Announces the Appointment of Mutya Harsch to its Board of Directors

Read More

Sep 28, 2021

Satsuma Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference

Read More